Get a sneak-peak at what’s coming up at the ATS 2023 later this month with today’s online release of the “American Thoracic Society International Conference Abstracts.”
Evidence-based practice changes led by nurses from Roswell Park Comprehensive Cancer Center will be highlighted at the 48th annual Oncology Nursing Society (ONS) Congress April 26-30, 2023, in San Antonio, Texas.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for April 2023.
One of the most highly-anticipated events at the ATS 2023 International Conference, which kicks off May 19, is the “Breaking News: Clinical Trial Results in Pulmonary Medicine.” Taking place on Monday, May 22, the series of presentations will focus on the latest regarding COPD and asthma treatment.
The 184th ASA Meeting will include three press conferences on Tuesday, May 9. The in-person presentations will also be livestreamed and recorded. Topics will focus on a wide range of newsworthy sessions, including 3D-printing head simulators, tracking immune cells with ultrasound, investigating the impact of skin color on breast cancer diagnosis, mimicking insects to create miniature microphones, and locating leaks in water networks. Reporters can register for in-person or virtual attendance.
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center and the Department of Urology at the David Geffen School of Medicine at UCLA will be joining thousands of urology experts on April 28 to May 1 for the American Urological Association (AUA) Annual Meeting.
Physician scientists from the UCLA Department of Pediatrics at the David Geffen School of Medicine at UCLA will present on the latest scientific advancements at the Pediatric Academic Societies (PAS) annual meeting April 27-May 1, 2023 in Washington, D.C.
The first prospective study comparing outcomes in patients with pituitary apoplexy—sudden bleeding or death of a pituitary tumor—found that patients managed medically fared as well as those treated surgically in the majority of cases.
A pilot study conducted at Hospital for Special Surgery (HSS) shows evidence that a mid-calf nerve block is a safe and effective regional anesthetic option for foot and ankle surgeries and may enable faster recovery of motor function of the ankle joint compared with a popliteal block. These findings were presented at the 2023 Spring American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Meeting.
The latest science and trial results were unveiled during the 2023 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Los Angeles. The late-breaking abstract “Efficacy and Safety of Early Minimally Invasive Removal of Intracerebral Hemorrhage (ENRICH): a Multicenter Randomized Adaptive Trial,” was showcased Saturday, April 22.
In a study conducted at Hospital for Special Surgery (HSS), researchers found that the use of peripheral nerve blocks in total knee and total hip arthroplasty were associated with a consistent reduction in risk for postoperative complications in patients with a lower comorbidity burden. In particular, the most consistent reduction in risk of complications and use of hospital resources was in older patients with no comorbidity burden. These findings were presented at the 2023 Spring American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Meeting and were acknowledged as one of the President’s Choice Abstracts.1
In the first few days after a traumatic brain injury (TBI), food is often an afterthought as clinicians focus on minimizing the damage to the brain.
Adverse childhood experiences (ACEs) contribute to reduced vascular function and diminished sleep quality in young adults, according to a study at the University of Iowa.
Repeated use of cannabigerol caused a drop in the blood pressure of healthy mice, according to a new study at Pennsylvania State University College of Medicine.
The time period in which muscles heal after injury may depend on biological sex, and applying personalized treatment may help optimize recovery, according to a new study.
Measuring stress activity directed to the blood vessels of muscles could allow researchers to measure pain objectively, according to a new study.
New research out of the University of Wisconsin-La Crosse finds that passive stretching before a run protected the vascular function of participants.
A five-minute test commonly used to evaluate olfactory function (sense of smell) could also help doctors screen for depression, according to new research out of King George’s Medical University, India.
New research results suggest that the widely used diabetes drug metformin may be beneficial for recovering from short periods of severe food insecurity or anorexia.
The underrepresentation of female research subjects has been documented from clinical trials down to sources for cell cultures. Now, researchers out of Marquette University in Milwaukee have found that in exercise research, this inequity correlates with the gender of the researchers conducting the study.
The drug atogepant may help prevent migraines for people who have had no success with other preventive drugs, according to a preliminary study released April 20, 2023, which will be presented at the American Academy of Neurology’s 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023. The study involved people with episodic migraine, which is defined as having up to 14 headache days per month with migraine characteristics.
A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease. The preliminary study, released April 19, 2023, will be presented at the American Academy of Neurology’s 75th Annual Meeting, being held in person in Boston and live online from April 22-27, 2023. Called radiologically isolated syndrome, the condition is diagnosed in people who do not have MS symptoms but who have abnormalities in the brain or spinal cord called lesions, similar to those seen in MS.
The Johns Hopkins Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health will host its annual World Malaria Day Symposium Tuesday, April 25, from 8:30 a.m. to 5:45 p.m. EDT. The theme is the blood stage of malaria, which is the most devastating phase of the disease. The event will take place in person in Baltimore with thirteen panelists. A remote option is available to journalists.
A new study shows that cardiovascular strain begins at lower temperature and humidity levels than those that cause increases in the body’s core temperature, and could inform revisions to safety guidelines and policies that help protect people during heat waves.
People who have an irregular heartbeat called atrial fibrillation that is treated with a procedure called catheter ablation may have a reduced risk of dementia compared to those who are treated with medication alone. The preliminary study released April 18, 2023, will be presented at the American Academy of Neurology’s 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.
A new study of elderly patients showed that those who exercised in the evening experienced a greater decrease in blood pressure compared to those who exercised in the morning.
Researchers from the University of Vermont have found that eating full-fat yogurt on a daily basis may help lower fasting glucose levels in middle-age and older adults with prediabetes.
Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia within six months compared to their peers without severe infection, according to research presented at EHRA 2023, a scientific congress of the European Society of Cardiology (ESC).1 Risks of other heart rhythm disorders were also elevated.
A new study by researchers at the American Cancer Society (ACS) shows almost three-quarters of a million more adults in the United States, ages 18-29 years, used e-cigarettes between 2019-2021 during the period that spanned the EVALI outbreak (E-cigarette or vaping product use–associated lung injury) and COVID-19 pandemic.
Researchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple clinical trials today at the American Association for Cancer Research (AACR) Annual Meeting 2023. The studies, which describe results from a novel FGFR inhibitor and from new PARP/ATR inhibitor combinations, were featured in a plenary session highlighting novel biomarker-driven molecularly targeted therapy trials.
Research led by Roswell Park's Sarbajit Mukherjee, MD, MS, shows that a new chemotherapy combination — trifluridine/tipiracil (FTD/TPI) and oxaliplatin — is well tolerated and has activity among patients with esophageal cancer.
Results of an anonymous cancer patient and survivor survey conducted by a team from Roswell Park Comprehensive Cancer Center’s Center for Translational Research on Cannabis and Cancer (CTRCC) will be shared at the American Association for Cancer Research 2023 Annual Meeting in Orlando.
Based on a large retrospective study, Roswell Park Comprehensive Cancer Center experts that many patients with early-stage breast cancer with rare variant histology, or tumor anatomy, benefit from chemotherapy.
University of Minnesota Twin Cities computer science researchers found that the nature of TikTok’s algorithm can have both positive and negative outcomes for users’ mental health and sense of belonging on the platform.
ISPOR—The Professional Society for Health Economics and Outcomes Research announced its ISPOR Real-World Evidence Summit 2023 scheduled for May 7 in Boston, MA, USA.
A study has found that ketamine may be more helpful in preventing postoperative pain among a subset of patients with a higher tendency toward central sensitization as measured by TSP (temporal summation of pain).
A retrospective chart review found a 3.7% occurrence rate of transient neurologic symptoms (TNS) in patients receiving 1.5% mepivacaine during Holmium Laser Enucleation of the Prostate (HoLEP) surgery and suggested a possible association of TNS development with quicker procedures, smaller prostates, lithotomy positioning, and younger age.
Using two targeted injections of local anesthetic medication may provide a comprehensive, effective means of pain control during breast cancer surgery, found a study by researchers at Western University, London, Ontario, Canada.
A review of medical literature found that infections following epidural and spinal blocks are rare. Infections following peripheral nerve block catheters are more common but have been less frequently studied; this may necessitate a review of patient and procedural aspects to lower the risk associated with these procedures.
A study using lower limbs from two cadavers to demonstrate the technique of adductor canal (AC) block found that the needle trajectory of the traditional approach led to impalement of the nerve to vastus medialis (NVM) in 33% of cases and direct contact with the nerve in another 22%.
A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that co-occurring mutations in three tumor suppressor genes – KEAP1, SMARCA4 and CDKN2A – are linked with poor clinical outcomes in patients with KRAS G12C-mutant non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitors adagrasib or sotorasib.
Using disinformation to create political instability and battlefield confusion dates back millennia. However, today’s disinformation actors use social media to amplify disinformation that users knowingly or, more often, unknowingly perpetuate. Such disinformation spreads quickly, threatening public health and safety. Indeed, the COVID-19 pandemic and recent global elections have given the world a front-row seat to this form of modern warfare.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center served as the lead site for a promising first-in-human clinical trial for patients with relapsed multiple myeloma. Patients treated with higher doses of the immunotherapy called REGN5459 resulted in a 90.5 percent overall response rate.
New research presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (Copenhagen, 15-18 April) and published in The Lancet Public Health shows that the impact of COVID-19 on mortality in people living with intellectual disabilities extended beyond deaths from the virus itself, and was linked with increased mortality in several other conditions.
The CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouraging response rates and disease control rates in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to results of a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center and presented today at the American Association for Cancer Research (AACR) Annual Meeting 2023.
New, never before presented research will be shared during the 2023 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Los Angeles. The late-breaking abstract “Efficacy and Safety of Early Minimally Invasive Removal of Intracerebral Hemorrhage (ENRICH): a Multicenter Randomized Adaptive Trial,” will be showcased during the Plenary Session l, Saturday, April 22, at 9:39 am- 9:49 am, PST.
ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for its annual international conference, ISPOR 2023. The conference is scheduled for May 7-10 in Boston, MA, USA.
The first-in-class YAP/TEAD inhibitor VT3989 was well tolerated with durable antitumor responses in patients with advanced malignant mesothelioma and other tumors with NF2 mutations, according to results of a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center.
Results from a preclinical study from Penn Medicine, presented at the AACR Annual Meeting 2023, verified a new target for drug-resistant ovarian cancer and provided data to support a treatment approach that is already making its way into clinical trials.
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to Phase III trial results presented today by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2023.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
